Paraneoplastic glomerular diseases and malignancies

Critical Reviews in Oncology/Hematology

Volumn 70, Issue 1, 2009, Pages 39-58

  Bacchetta, Justine ^a,b   Juillard, Laurent ^b   Cochat, Pierre ^a,b   Droz, Jean Pierre ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Cancer; Carcinoma; Membranous nephropathy; Nephrotic syndrome; Paraneoplastic glomerular disease

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MITOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB;

FOLLOW UP; GASTROINTESTINAL CARCINOMA; GLOMERULOPATHY; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INFECTION; KIDNEY BIOPSY; KIDNEY CANCER; LUNG CARCINOMA; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PARANEOPLASTIC GLOMERULOPATHY; PARANEOPLASTIC SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PROTEINURIA; REVIEW; SOLID TUMOR; THROMBOSIS;

GLOMERULONEPHRITIS; HUMANS; NEOPLASMS; PARANEOPLASTIC SYNDROMES;

EID: 62349112195     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.08.003     Document Type: Review

References (252)

1. Ronco P.M. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56 1 (1999) 355-377
2. Galloway J. Remarks on Hodgkin's disease. Br Med J 2 (1922) 1201-1204
3. Lefaucheur C., Stengel B., Nochy D., et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 70 8 (2006) 1510-1517
4. Eagen J.W. Glomerulopathies of neoplasia. Kidney Int 11 5 (1977) 297-303
5. Davison A.M. Renal diseases associated with malignancies. Nephrol Dial Transplant 16 Suppl. 6 (2001) 13-14
6. Tourneur F., Bouvier R., Langue J., et al. Membranous nephropathy and orbital malignant tumor. Pediatr Nephrol 14 1 (2000) 53-55
7. Audard V., Larousserie F., Grimbert P., et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 69 12 (2006) 2251-2260
8. ANAES. Guide d'analyse de la littérature et gradation des recommandations, 2000. In www.anaes.fr.
9. Lee J.C., Yamauchi H., and Hopper Jr. J. The association of cancer and the nephrotic syndrome. Ann Intern Med 64 1 (1966) 41-51
10. Zech P., Colon S., Pointet P., Deteix P., Labeeuw M., and Leitienne P. The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol 17 5 (1982) 232-236
11. O'Callaghan C.A., Hicks J., Doll H., Sacks S.H., and Cameron J.S. Characteristics and outcome of membranous nephropathy in older patients. Int Urol Nephrol 33 1 (2002) 157-165
12. Kingswood J.C., Banks R.A., Tribe C.R., Owen-Jones J., and Mackenzie J.C. Renal biopsy in the elderly: clinicopathological correlations in 143 patients. Clin Nephrol 22 4 (1984) 183-187
13. Brueggemeyer C.D., and Ramirez G. Membranous nephropathy: a concern for malignancy. Am J Kidney Dis 9 1 (1987) 23-26
14. Birkeland S.A., and Storm H.H. Glomerulonephritis and malignancy: a population-based analysis. Kidney Int 63 2 (2003) 716-721
15. Jorgensen L., Heuch I., Jenssen T., and Jacobsen B.K. Association of albuminuria and cancer incidence. J Am Soc Nephrol 19 5 (2008) 992-998
16. Puolijoki H., Mustonen J., Pettersson E., Pasternack A., and Lahdensuo A. Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 4 11 (1989) 947-950
17. Sawyer N., Wadsworth J., Wijnen M., and Gabriel R. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J (Clin Res Ed) 296 6632 (1988) 1295-1298
18. Larsen S. Glomerular immune deposits in kidneys from patients with no clinical or light microscopic evidence of glomerulonephritis. Assessment of the influence of autolysis on identification of immunoglobulins and complement. Acta Pathol Microbiol Scand [A] 87A 5 (1979) 313-319
19. Beaufils H., Jouanneau C., and Chomette G. Kidney and cancer: results of immunofluorescence microscopy. Nephron 40 3 (1985) 303-308
20. Davis S., Marquet E., Rambotti P., and Sobel H.J. Electron microscopic and immunohistochemical analysis of glomerular deposits in patients with bronchogenic carcinoma. Ultrastruct Pathol 1 4 (1980) 527-531
21. Davison A., and Hartley B. Malignancy-associated glomerular disease. In: Davison A., Cameron J., Grünfeld J., Ponticelli C., Ritz E., Winearls C., et al. (Eds). Oxford textbook of clinical nephrology (2005), Oxford University Press, Oxford 625-638
22. Barton C.H., Vaziri N.D., and Spear G.S. Nephrotic syndrome associated with adenocarcinoma of the breast. Am J Med 68 2 (1980) 308-312
23. Lumeng J., and Moran J.F. Carotid body tumor associated with mild membranous glomerulonephritis. Ann Intern Med 65 6 (1966) 1266-1270
24. Beauvais P., Vaudour G., Boccon Gibod L., and Levy M. Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal. Eur J Pediatr 148 7 (1989) 624-625
25. Burstein D.M., Korbet S.M., and Schwartz M.M. Membranous glomerulonephritis and malignancy. Am J Kidney Dis 22 1 (1993) 5-10
26. Karras A., de Montpreville V., Fakhouri F., Grunfeld J.P., and Lesavre P. Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature. Nephrol Dial Transplant 20 6 (2005) 1075-1082
27. Hoffacker V., Schultz A., Tiesinga J.J., et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96 12 (2000) 3872-3879
28. Wakashin M., Wakashin Y., Iesato K., et al. Association of gastric cancer and nephrotic syndrome. An immunologic study in three patients. Gastroenterology 78 4 (1980) 749-756
29. Yamauchi H., Linsey M.S., Biava C.G., and Hopper Jr. J. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 145 11 (1985) 2061-2063
30. Couser W.G., Wagonfeld J.B., Spargo B.H., and Lewis E.J. Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 57 6 (1974) 962-970
31. Cairns S.A., Mallick N.P., Lawler W., and Williams G. Squamous cell carcinoma of bronchus presenting with Henoch-Schonlein purpura. Br Med J 2 6135 (1978) 474-475
32. Row P.G., Cameron J.S., Turner D.R., et al. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med 44 174 (1975) 207-239
33. Haas M., Meehan S.M., Karrison T.G., and Spargo B.H. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30 5 (1997) 621-631
34. Donadio Jr. J.V., Torres V.E., Velosa J.A., et al. Idiopathic membranous nephropathy: the natural history of untreated patients. Kidney Int 33 3 (1988) 708-715
35. Kida H., Asamoto T., Yokoyama H., Tomosugi N., and Hattori N. Long-term prognosis of membranous nephropathy. Clin Nephrol 25 2 (1986) 64-69
36. Noel L.H., Zanetti M., Droz D., and Barbanel C. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 66 1 (1979) 82-90
37. Reich M. Membranous nephropathy. In: Davison A.M., Grunfeld J.P., Ponticelli C., Ritz E., Wincarls C., and Ypersele C. (Eds). Oxford textbook of clinical nephrology (2005), Oxford University Press, Oxford 502-522
38. Chavaz A., Mignon F., Morel-Maroger L., and Richet G. Extramembranous glomerulitis. Apropos of 92 cases. Schweiz Med Wochenschr 107 26 (1977) 899-907
39. Cahen R., Francois B., Trolliet P., Gilly J., and Parchoux B. Aetiology of membranous glomerulonephritis: a prospective study of 82 adult patients. Nephrol Dial Transplant 4 3 (1989) 172-180
40. Loughridge L.W., and Lewis M.G. Nephrotic syndrome in malignant disease of non-renal origin. Lancet 1 7693 (1971) 256-258
41. Higgins M.R., Randall R.E., and Still W.J. Nephrotic syndrome with oat-cell carcinoma. Br Med J 3 5928 (1974) 450-451
42. Weintroub S., Stavorovsky M., and Griffel B. Membranous glomerulonephritis. An initial symptom of gastric carcinoma?. Arch Surg 110 7 (1975) 833-838
43. Papadimitriou K., Nakopoulou L., Billalis D., and Papacharalampous X.N. A chordoma of sacrococcygeal region as a cause of nephrotic syndrome (author's transl.). Zentralbl Allg Pathol 120 6 (1976) 500-504
44. Kerpen H.O., Bhat J.G., Feiner H.D., and Baldwin D.S. Membranes nephropathy associated with renal cell carcinoma. Evidence against a role of renal tubular or tumor antibodies in pathogenesis. Am J Med 64 5 (1978) 863-867
45. Rose J.D. Membranous glomerulonephritis, dermatomyositis, and bronchial carcinoma. Br Med J 2 6191 (1979) 641
46. Posner M.R., Prout M.N., and Berk S. Thymoma and the nephrotic syndrome: a report of a case. Cancer 45 2 (1980) 387-391
47. Ducret F., Pointet P., Bonnet P., and Martin D. Membranous glomerulonephritis associated with esophageal carcinoma (author's transl). Schweiz Rundsch Med Prax 70 12 (1981) 519-520
48. Heckerling P.S. Esophageal carcinoma with membranous nephropathy. Ann Intern Med 103 3 (1985) 474
49. Stuart K., Fallon B.G., and Cardi M.A. Development of the nephrotic syndrome in a patient with prostatic carcinoma. Am J Med 80 2 (1986) 295-298
50. Goldstein D., Kelly R., Ralston M., Penny R., and Hayes J. Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma. Med Oncol Tumor Pharmacother 4 2 (1987) 101-105
51. Hruby Z., Kuzniar J., and Wnukiewicz J. Membranous glomerulonephritis in a patient with squamous cell carcinoma of the mandible. Pol Tyg Lek 43 31-32 (1988) 1021-1022
52. Lopez-Navidad A., Colomina J., Domingo P., Franco M., and Algaba F. Nephrotic syndrome associated with ampulloma. Rev Esp Enferm Apar Dig 75 6 Pt 2 (1989) 691-693
53. Coma-del-Corral M.J., Razquin S., Pascual S., Bengoechea M.P., Gutierrez E., and Yuguero L. Liver cell adenoma associated with membranous nephropathy. Nephron 57 1 (1991) 117-118
54. Cudkowicz M.E., Sayegh M.H., and Rennke H.G. Membranous nephropathy in a patient with renal cell carcinoma. Am J Kidney Dis 17 3 (1991) 349-351
55. Lai K.N., Li P.K., Lai F.M., and Ng H.K. Membranous nephropathy associated with spinal schwannoma. Pathology 23 3 (1991) 250-253
56. Tachibana A., Suzuki K., Hatakeyama S., Nagayama M., and Okano H. A case of nephrotic syndrome associated with bronchogenic carcinoma. Nihon Kyobu Shikkan Gakkai Zasshi 30 7 (1992) 1350-1354
57. Stein H.D., Yudis M., Sirota R.A., Snipes E.R., and Gronich J.H. Membranous nephropathy associated with renal cell carcinoma. Am J Kidney Dis 22 2 (1993) 352
58. Boon E.S., Vrij A.A., Nieuwhof C., van Noord J.A., and Zeppenfeldt E. Small cell lung cancer with paraneoplastic nephrotic syndrome. Eur Respir J 7 6 (1994) 1192-1193
59. Ninet J., Naouri A., Colon S., et al. Triple association: extramembranous glomerulonephritis, renal adenocarcinoma and splenic hamartoma. Apropos of a case. Rev Med Intern 15 8 (1994) 546-554
60. Gomez Carrera L., Prados C., Alvarez-Sala R., Garcia Rio T., Villamor J., and Martinez-Ara J. Membranous glomerulonephritis and melanoma: a causal correlation?. J Natl Cancer Inst 86 1 (1994) 64-65
61. Schneider B.F., Glass II W.F., Brooks C.H., and Koenig K.G. Membranous glomerulonephritis associated with testicular seminoma. J Intern Med 237 6 (1995) 599-602
62. Wagrowska-Danilewicz M., and Danilewicz M. Glomerulonephritis associated with malignant diseases of non-renal origin. A report of three cases and a review of the literature. Pol J Pathol 46 3 (1995) 195-198
63. Kon S.P., Fan S.L., Kwan J.T., Dodd S.M., and Raftery M.J. Membranous nephropathy complicating adenolymphoma of the parotid (Warthin's tumour). Nephron 73 4 (1996) 692-694
64. Nishibara G., Sukemi T., Ikeda Y., and Tomiyoshi Y. Nephrotic syndrome due to membranous nephropathy associated with renal cell carcinoma. Clin Nephrol 45 6 (1996) 424
65. Becker B.N., Goldin G., Santos R., et al. Carcinoid tumor and the nephrotic syndrome: a novel association between neoplasia and glomerular disease. South Med J 89 2 (1996) 240-242
66. Waki M., Ishimura E., Morii H., et al. A case of membranous glomerulonephritis associated with gastric cancer. Osaka City Med J 43 1 (1997) 95-105
67. Arnal Babiloni M., Cabades O'Callaghan F., Cortes V., and Polo J.A. Membranous glomerulonephritis secondary to retroperitoneal sarcoma. Med Clin (Barc) 109 9 (1997) 356-357
68. Baris Y.S., Akpolat T., Akpolat I., Karagoz F., and Kandemir B. Coexistence of membranous glomerulonephritis and Kaposi's sarcoma. Nephron 79 3 (1998) 371-372
69. Helin K., Honkanen E., Metsaniitty J., and Tornroth T. A case of membranous glomerulonephritis associated with adenocarcinoma of pancreas. Nephrol Dial Transplant 13 4 (1998) 1049-1050
70. Tomida C., Yamagata K., Ishizu T., et al. A case of nephrotic syndrome associated with myasthenia gravis and malignant thymoma. Nippon Jinzo Gakkai Shi 41 2 (1999) 77-82
71. Galesic K., Bozic B., Heinzl R., Scukanec-Spoljar M., and Bozikov V. Pleural mesothelioma and membranous nephropathy. Nephron 84 1 (2000) 71-74
72. Sakamoto K., Suzuki H., and Jojima T. Membranous glomerulonephritis associated with diffuse malignant pleural mesothelioma: report of a case. Surg Today 30 12 (2000) 1124-1126
73. Ashman N., Steele J.P., Sheaff M., Rudd R.M., and Onwubalili J. Membranous nephropathy resolving with treatment of bronchial carcinoid tumor. Am J Kidney Dis 36 3 (2000) E15
74. Matsuura H., Sakurai M., and Arima K. Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: rapid remission after initial endocrine therapy. Nephron 84 1 (2000) 75-78
75. Porush J.G. Membranous nephropathy and prostatic carcinoma. Nephron 86 4 (2000) 536
76. Fang J.T., Chen Y.C., and Hsueh S. Lymphatic tumor emboli of perirenal fat in patient with nephrotic syndrome receiving renal biopsy, ultimately revealed gastric adenocarcinoma with membranous glomerulonephritis. Ren Fail 23 5 (2001) 743-748
77. Grivaux M., Renault D., Gallois J.C., Barbanel C., and Blanchon F. Small cell lung cancer revealed by extramembranous glomerulonephritis. Rev Mal Respir 18 2 (2001) 197-199
78. Togawa A., Yamamoto T., Suzuki H., et al. Membranous glomerulonephritis associated with renal cell carcinoma: failure to detect a nephritogenic tumor antigen. Nephron 90 2 (2002) 219-221
79. Ng S.B., Tan P.H., Chuah K.L., Cheng C., and Tan J. A case of juxtaglomerular cell tumor associated with membranous glomerulonephritis. Ann Diagn Pathol 7 5 (2003) 314-320
80. Meydanli M.M., Erguvan R., Altinok M.T., Ataoglu O., and Kafkasli A. Rare case of neuroendocrine small cell carcinoma of the endometrium with paraneoplastic membranous glomerulonephritis. Tumori 89 2 (2003) 213-217
81. Fabbian F., Rizzioli E., and Catalano C. Membranous glomerulonephritis and transitional cell carcinoma, improved proteinuria after each tumor resection. G Ital Nefrol 20 1 (2003) 65-68
82. Altiparmak M.R., Pamuk O.N., Pamuk G.E., and Ozbay G. Membranous glomerulonephritis in a patient with choriocarcinoma: case report. South Med J 96 2 (2003) 198-200
83. Ohtani H., Wakui H., Komatsuda A., et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 19 3 (2004) 574-579
84. Kijima Y., Yoshinaka H., Owaki T., et al. Breast cancer with nephrotic syndrome: report of two cases. Surg Today 34 9 (2004) 755-759
85. Wadhwa N.K., Gupta M., Afolabi A., and Miller F. Membranous glomerulonephritis in a patient with an adrenal ganglioneuroma. Am J Kidney Dis 44 2 (2004) 363-368
86. Texier F., Dharancy S., Provot F., et al. Membranous glomerulonephritis complicating hepatocellular carcinoma. Gastroenterol Clin Biol 28 6-7 Pt 1 (2004) 605-607
87. Yoshimoto K., Yokoyama H., Wada T., et al. Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. Kidney Int 65 1 (2004) 148-153
88. Fujita Y., Kashiwagi T., Takei H., et al. Membranous nephropathy complicated by renal cell carcinoma. Clin Exp Nephrol 8 1 (2004) 59-62
89. Kapoulas S., Liakos S., Karkavelas G., Grekas D., and Giannoulis E. Membranous glomerulonephritis associated with renal cell carcinoma. Clin Nephrol 62 6 (2004) 476-477
90. Valcamonico F., Ferrari V., Simoncini E., et al. Paraneoplastic nephrotic syndrome in advanced breast cancer patient. A case report. Tumori 90 1 (2004) 154-156
91. Kuroda I., Ueno M., Okada H., et al. Nephrotic syndrome as a result of membranous nephropathy caused by renal cell carcinoma. Int J Urol 11 4 (2004) 235-238
92. Menivale F., Deslee G., Garcia V., Sartelet H., Wynckel A., and Lebargy F. Paraneoplastic nephrotic syndrome associated with broncho-pulmonary cancer. Rev Mal Respir 22 2 Pt 1 (2005) 325-329
93. Rihova Z., Honsova E., Merta M., et al. Secondary membranous nephropathy-one center experience. Ren Fail 27 4 (2005) 397-402
94. Mallouk A., Pham P.T., and Pham P.C. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol 10 4 (2006) 284-289
95. Kerjaschki D., Horvat R., Binder S., et al. Identification of a 400-kDa protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis. Am J Pathol 129 1 (1987) 183-191
96. Costanza M.E., Pinn V., Schwartz R.S., and Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med 289 10 (1973) 520-522
97. Borochovitz D., Kam W.K., Nolte M., Graner S., and Kiss J. Adenocarcinoma of the palate associated with nephrotic syndrome and epimembranous carcinoembryonic antigen deposition. Cancer 49 10 (1982) 2097-2102
98. Pascal R.R., and Slovin S.F. Tumor directed antibody and carcinoembryonic antigen in the glomeruli of a patient with gastric carcinoma. Hum Pathol 11 6 (1980) 679-682
99. Haskell L.P., Fusco M.J., Wadler S., Sablay L.B., and Mennemeyer R.P. Crescentic glomerulonephritis associated with prostatic carcinoma: evidence of immune-mediated glomerular injury. Am J Med 88 2 (1990) 189-192
100. Olson J.L., Philips T.M., Lewis M.G., and Solez K. Malignant melanoma with renal dense deposits containing tumor antigens. Clin Nephrol 12 2 (1979) 74-82
101. Bernatsky S., Ramsey-Goldman R., and Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 18 2 (2006) 129-134
102. Meynier A. Minimal change disease and focal and segmental glomerulosclerosis. In: Davison A.M., Grunfeld J.P., Ponticelli C., Ritz E., Wincarls C., and Ypersele C. (Eds). Oxford textbook of clinical nephrology (2005), Oxford University Press, Oxford 439-468
103. Varsano S., Bruderman I., Bernheim J.L., Rathaus M., and Griffel B. Minimal-change nephropathy and malignant thymoma. Chest 77 5 (1980) 695-697
104. Forland M., and Bannayan G.A. Minimal-change lesion nephrotic syndrome with renal oncocytoma. Am J Med 75 4 (1983) 715-720
105. Hillion D., Molho M., Oberlin P., Felsenheld C., Bruet A., and Fendler J.P. Nephrotic syndrome with minimal glomerular lesions, sensitive to corticoids, disclosing a chordoid sarcoma. Ann Med Interne (Paris) 135 4 (1984) 274-277
106. Singer C.R., and Boulton-Jones J.M. Minimal change nephropathy associated with anaplastic carcinoma of bronchus. Postgrad Med J 62 725 (1986) 213-217
107. Cases A., Torras A., Lens X.M., and Revert L. Minimal-change nephrotic syndrome associated with an undifferentiated urothelial carcinoma. Med Clin (Barc) 86 10 (1986) 436
108. Hirokawa M., Moriya T., and Manabe T. Minimal change renal disease associated with thymoma and pancreatic carcinoma. Acta Pathol Jpn 36 7 (1986) 1075-1081
109. Whelan T.V., and Hirszel P. Minimal-change nephropathy associated with pancreatic carcinoma. Arch Intern Med 148 4 (1988) 975-976
110. Chan P.C., Lau C.C., Cheng I.K., Chan K.W., Jones B.M., and Chan M.K. Minimal change glomerulopathy in two patients after thymectomy. Singapore Med J 31 1 (1990) 46-47
111. McDonald P., Kalra P.A., and Coward R.A. Thymoma and minimal-change glomerulonephritis. Nephrol Dial Transplant 7 4 (1992) 357-359
112. Meyrier A., Delahousse M., Callard P., and Rainfray M. Minimal change nephrotic syndrome revealing solid tumors. Nephron 61 2 (1992) 220-223
113. Gallego E., Albarracin C., Campdera F.G., Moro E., and Valderrabano F. Minimal change glomerular disease in association with a carcinoma of the esophagus. Nephron 66 2 (1994) 238-239
114. Caruana R.J., and Griffin Jr. J.W. Nephrotic syndrome in a patient with ulcerative colitis and colonic carcinoma. Am J Gastroenterol 74 6 (1980) 525-528
115. McCanse L.R., Moore J.D., Markel L., and Mebust W.K. Renal cell carcinoma presenting with nephrotic syndrome: a case report and review of the literature. J Urol 114 6 (1975) 938-939
116. Moorthy A.V. Minimal change glomerular disease: a paraneoplastic syndrome in two patients with bronchogenic carcinoma. Am J Kidney Dis 3 1 (1983) 58-62
117. Borras M., Panades M.J., Ramos J., and Montoliu J. Minimal-change nephrotic syndrome associated with renal angiomyolipoma. Nephron 68 1 (1994) 138-139
118. Tashiro M., Yokoyama K., Nakayama M., et al. A case of nephrotic syndrome developing during postoperative gamma interferon therapy for renal cell carcinoma. Nephron 73 4 (1996) 685-688
119. Abouchacra S., Duguid W.P., and Somerville P.J. Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure. Clin Nephrol 39 6 (1993) 340-342
120. Tan Y.O., Woo K.T., Chiang G.S., Pwee H.S., Yeo P.P., and Khoo O.T. Nephrotic syndrome associated with malignant tumours. Ann Acad Med Singapore 11 1 (1982) 57-60
121. Hiromura K., Fukushima Y., Tsukada Y., et al. Nephrotic syndrome associated with liver metastasis of rectal cancer. Nephron 69 4 (1995) 485-486
122. Rapoport J., Kuperman O., Gopas Y., et al. Nephrotic syndrome associated with transitional cell carcinoma of the bladder. Nephron 52 1 (1989) 36-39
123. Martinez-Vea A., Panisello J.M., Garcia C., et al. Minimal-change glomerulopathy and carcinoma. Report of two cases and review of the literature. Am J Nephrol 13 1 (1993) 69-72
124. Gandini E., Allaria P., Castiglioni A., d'Amato I., Schiaffino E., and Giangrande A. Minimal change nephrotic syndrome with cecum adenocarcinoma. Clin Nephrol 45 4 (1996) 268-270
125. Sood A.K., Dua A., Mahajan A., and Sharma R. Minimal change nephrotic syndrome associated with extrarenal neurilemmoma. Nephron 75 2 (1997) 230-232
126. Ishida I., Hirakata H., Kanai H., et al. Steroid-resistant nephrotic syndrome associated with malignant thymoma. Clin Nephrol 46 5 (1996) 340-346
127. Scadding G.K., Sweny P., Wilson S.G., Havard C.W., and Newsom-Davis J. Glomerulonephritis, thymoma and myasthenia gravis. Q J Med 52 206 (1983) 187-193
128. Ogawa M., Ueda S., Ohto M., et al. Minimal change nephrotic syndrome developed after non-surgical treatment of a thymoma. Clin Nephrol 38 3 (1992) 171-172
129. Zinger C., Ben-Itzhak O., Szylman P., Green J., and Nakhoul F. Minimal-change nephropathy and malignant thymoma. Am J Nephrol 18 1 (1998) 61-63
130. Auguet T., Lorenzo A., Colomer E., et al. Recovery of minimal change nephrotic syndrome and acute renal failure in a patient with Renal cell carcinoma. Am J Nephrol 18 5 (1998) 433-435
131. Yamagata T., Akamatsu K., Kuroda M., et al. Squamous cell lung cancer with minimal-change nephrotic syndrome. Nihon Kokyuki Gakkai Zasshi 36 12 (1998) 1032-1037
132. Macanovic M., and Peat D. Minimal change nephropathy with adenocarcinoma of breast. J R Soc Med 93 10 (2000) 539
133. Lee H.C., Cheng Y.F., Chuang F.R., Chen J.B., and Hsu K.T. Minimal change nephrotic syndrome associated with malignant thymoma: case report and literature review. Chang Gung Med J 24 9 (2001) 576-581
134. Taniguchi K., Fujioka H., Torashima Y., Yamaguchi J., Izawa K., and Kanematsu T. Rectal cancer with paraneoplastic nephropathy: association of vascular endothelial growth factor. Dig Surg 21 5-6 (2004) 455-457
135. Ryu D.R., Yoo T.H., Kim Y.T., Jeong H.J., Cho N.H., and Kang S.W. Minimal change disease in a patient with ovarian papillary serous carcinoma. Gynecol Oncol 93 2 (2004) 554-556
136. Shields J.A., Narsipur S.S., Shields C.L., and Sperber D.E. Choroidal melanoma in an immunosuppressed child with minimal change nephrotic syndrome. Retina 24 3 (2004) 454-455
137. Stuart S., and Chandran P.K. Oncogenic Cushing's syndrome and nephrotic syndrome in the same patient. Am J Kidney Dis 37 4 (2001) E28
138. Schroeter N.J., Rushing D.A., Parker J.P., and Beltaos E. Minimal-change nephrotic syndrome associated with malignant mesothelioma. Arch Intern Med 146 9 (1986) 1834-1836
139. Yoshida T., Suzuki T., Suzuki S., et al. Nephrotic syndrome after extended thymectomy for thymoma with myasthenia gravis; report of a case. Kyobu Geka 59 3 (2006) 247-250
140. Miyajima S., Taguchi Y., Tanaka E., et al. A case of pulmonary adenocarcinoma accompanied by minimal change nephrotic syndrome, antiphospholipid syndrome and warm-type autoimmune hemolytic anemia. Nihon Kokyuki Gakkai Zasshi 44 9 (2006) 631-635
141. Le Berre L., Herve C., Buzelin F., Usal C., Soulillou J.P., and Dantal J. Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo/Mna rats. Kidney Int 68 5 (2005) 2079-2090
142. Le Berre L., Godfrin Y., Gunther E., et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 109 4 (2002) 491-498
143. Robson A.M., Giangiacomo J., Kienstra R.A., Naqvi S.T., and Ingelfinger J.R. Normal glomerular permeability and its modification by minimal change nephrotic syndrmone. J Clin Invest 54 5 (1974) 1190-1199
144. Kitano Y., Yoshikawa N., and Nakamura H. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 40 4 (1993) 199-204
145. de Zoysa J.R., and Topham P.S. Podocyte biology in human disease. Nephrology (Carlton) 10 4 (2005) 362-367
146. Topaloglu R., Saatci U., Arikan M., Canpinar H., Bakkaloglu A., and Kansu E. T-cell subsets, interleukin-2 receptor expression and production of interleukin-2 in minimal change nephrotic syndrome. Pediatr Nephrol 8 6 (1994) 649-652
147. Yokoyama H., Kida H., Abe T., Koshino Y., Yoshimura M., and Hattori N. Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults. Clin Exp Immunol 70 1 (1987) 110-115
148. Cheong H.I., Lee J.H., Hahn H., Park H.W., Ha I.S., and Choi Y. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome. J Nephrol 14 4 (2001) 263-269
149. Mathieson P.W. How much VEGF do you need?. J Am Soc Nephrol 17 3 (2006) 602-603
150. Yang J.C., Haworth L., Sherry R.M., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349 5 (2003) 427-434
151. Doi K., Noiri E., Nakao A., Fujita T., Kobayashi S., and Tokunaga K. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 17 3 (2006) 823-830
152. Chan J.C., and Trachtman H. Modulating the progression in IgA nephropathy. Nephron Clin Pract 104 1 (2006) c61-c68
153. Schena F.P. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 89 2 (1990) 209-215
154. Schena F.P. Ig-A nephropathy. In: Davison A.M., Grunfeld J.P., Ponticelli C., Ritz E., Wincarls C., and Ypersele C. (Eds). Oxford textbook of clinical nephrology (2005), Oxford University Press, Oxford 469-502
155. Hogg R.J., Silva F.G., Wyatt R.J., Reisch J.S., Argyle J.C., and Savino D.A. Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 8 1 (1994) 15-20
156. Coppo R., Mazzucco G., Cagnoli L., Lupo A., and Schena F.P. Long-term prognosis of Henoch-Schonlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schonlein purpura. Nephrol Dial Transplant 12 11 (1997) 2277-2283
157. Schena F.P. Immunogenetic aspects of primary IgA nephropathy. Kidney Int 48 6 (1995) 1998-2013
158. Mustonen J. IgA glomerulonephritis and associated diseases. Ann Clin Res 16 3 (1984) 161-166
159. Mustonen J., Pasternack A., and Helin H. IgA mesangial nephropathy in neoplastic diseases. Contrib Nephrol 40 (1984) 283-291
160. Smith S.M., Welford A., Chiovetti R., and Hoy W.E. Alcohol abuse-related mesangial glomerulonephritis: immunoelectron microscopy. J Histochem Cytochem 38 5 (1990) 699-702
161. Smith S.M., Yu G.S., and Tsukamoto H. IgA nephropathy in alcohol abuse. An animal model. Lab Invest 62 2 (1990) 179-184
162. Coppo R., Arico S., Piccoli G., et al. Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritis. Clin Immunol Immunopathol 35 1 (1985) 1-8
163. Mustonen J., Helin H., and Pasternack A. IgA nephropathy associated with bronchial small-cell carcinoma. Am J Clin Pathol 76 5 (1981) 652-656
164. Abu-Romeh S.H., al-Adnani M.S., and Asfar S. Renal cell carcinoma presenting with acute renal failure and IgA glomerulonephritis. Nephron 50 2 (1988) 169-170
165. Sessa A., Volpi A., Tetta C., et al. IgA mesangial nephropathy associated with renal cell carcinoma. Appl Pathol 7 3 (1989) 188-191
166. Tanaka K., Kanzaki H., and Taguchi T. IgA glomerulonephritis in a patient with renal cell carcinoma. Nippon Jinzo Gakkai Shi 33 1 (1991) 87-90
167. Schutte W., Ohlmann K., Koall W., Rosch B., and Osten B. Paraneoplastic IgA nephritis as the initial symptom of bronchial carcinoma. Pneumologie 50 7 (1996) 494-495
168. Lam K.Y., Law S.Y., Chan K.W., and Yuen M.C. Glomerulonephritis associated with basaloid squamous cell carcinoma of the oesophagus. A possible unusual paraneoplastic syndrome. Scand J Urol Nephrol 32 1 (1998) 61-63
169. Tomoda K., Hamada K., Fukuoka K., et al. Small cell lung cancer associated with nephrotic syndrome: remission after chemotherapy. Nihon Kokyuki Gakkai Zasshi 36 6 (1998) 541-544
170. Magyarlaki T., Kiss B., Buzogany I., Fazekas A., Sukosd F., and Nagy J. Renal cell carcinoma and paraneoplastic IgA nephropathy. Nephron 82 2 (1999) 127-130
171. Ceres F., Rivera F., Yague J.L., et al. Non-Hodgkin lymphoma, IgA nephropathy and renal cell carcinoma. Nefrologia 23 6 (2003) 554-557
172. Novak J., Julian B.A., Tomana M., and Mesteck J. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21 5 (2001) 310-327
173. Kellerman P.S. Henoch-Schonlein purpura in adults. Am J Kidney Dis 48 6 (2006) 1009-1016
174. Pertuiset E., Liote F., Launay-Russ E., Kemiche F., Cerf-Payrastre I., and Chesneau A.M. Adult Henoch-Schonlein purpura associated with malignancy. Semin Arthritis Rheum 29 6 (2000) 360-367
175. Pankhurst T., Savage C.O., Gordon C., and Harper L. Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43 12 (2004) 1532-1535
176. Nan D.N., Fernandez-Ayala M., Garcia-Ibarbia C., Gutierrez-Santiago M., and Hernandez J.L. Henoch-Schonlein purpura after intravesical administration of bacillus Calmette-Guerin. Scand J Infect Dis 37 8 (2005) 613-615
177. Daskalakis N., and Winn M.P. Focal and segmental glomerulosclerosis. Cell Mol Life Sci 63 21 (2006) 2506-2511
178. Kriz W., Elger M., Nagata M., et al. The role of podocytes in the development of glomerular sclerosis. Kidney Int Suppl 45 (1994) S64-S72
179. Meyrier A. Mechanisms of disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol 1 1 (2005) 44-54
180. Endoh M., Nishizawa K., Suga T., et al. Focal segmental glomerulosclerosis associated with a pheochromocytoma. Tokai J Exp Clin Med 9 3 (1984) 191-197
181. Absy M., Gazzawi B., and Amoah E. Focal and segmental glomerulosclerosis associated with malignant mesothelioma. Nephron 60 2 (1992) 250
182. Jayasena S.D., Woolfson R.G., Griffiths M.H., and Neild G.H. Nephrotic syndrome, malignant thymoma, and myasthenia gravis. Case report and review of the literature. Am J Nephrol 15 4 (1995) 361-363
183. Kiss B., Magyarlaki T., Buzogany I., Fazekas A., Sukosd F., and Nagy J. Paraneoplastic nephropathy associated with adult renal carcinoma (immunologic and clinicopathologic study). Orv Hetil 140 2 (1999) 75-80
184. Konoshita T., Itoh M., Hatakeyama S., et al. Nephrotic syndrome due to focal glomerulosclerosis and undifferentiated carcinoma. Clin Nephrol 54 5 (2000) 404-408
185. Lin F.C., Chen J.Y., Yang A.H., and Chang S.C. The association of non-small-cell lung cancer, focal segmental glomerulosclerosis, and platelet dysfunction. Am J Med Sci 324 3 (2002) 161-165
186. Loi S., Perry G.J., Standish H., and Dowling J. Glomerulosclerosis: a paraneoplastic phenomenon?. Nephrology (Carlton) 9 6 (2004) 387-391
187. Teh H.S., Halim A.G., Soehardy Z., Fauzi A.R., and Kong C.T. Molar pregnancy and glomerulonephritis. Med J Malaysia 61 3 (2006) 361-362
188. Feriozzi S., Giannakakis K., Ranalli T.V., Pofi E., Gomes V., and Ancarani E. Renal oncocytoma associated with necrotizing glomerulonephritis. Ren Fail 28 2 (2006) 181-183
189. Markowitz G.S., Appel G.B., Fine P.L., et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12 6 (2001) 1164-1172
190. Appel G.B., Cook H.T., Hageman G., et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16 5 (2005) 1392-1403
191. Karim M., Hill P., Pillai G., Gatter K., Davies D.R., and Winearls C.G. Proliferative glomerulonephritis associated with mantle cell lymphoma-natural history and effect of treatment in 2 cases. Clin Nephrol 61 6 (2004) 422-428
192. Heaton J.M., Menzin M.A., and Carney D.N. Extrarenal malignancy and the nephrotic syndrome. J Clin Pathol 28 12 (1975) 944-946
193. Thorner P., McGraw M., Weitzman S., Balfe J.W., Klein M., and Baumal R. Wilms' tumor and glomerular disease. Occurrence with features of membranoproliferative glomerulonephritis and secondary focal, segmental glomerulosclerosis. Arch Pathol Lab Med 108 2 (1984) 141-146
194. Sirpal Y.M. Thymoma presenting as nephrotic syndrome-an unusual case report and review of literature. Indian J Cancer 32 2 (1995) 89-92
195. Nomura S., Takeda M., Manabe T., et al. Case report: intraglomerular metastasis with neoplastic cell interposition. Am J Med Sci 309 3 (1995) 179-182
196. Ahmed M., Solangi K., Abbi R., and Adler S. Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis. J Am Soc Nephrol 8 5 (1997) 848-852
197. Sartelet H., Melin J.P., Wynckel A., Lallemand A., Brambilla E., and Chanard J. Membranoproliferative glomerulonephritis (MPGN) and pulmonary carcinoid tumour. Nephrol Dial Transplant 12 11 (1997) 2405-2406
198. Reshi A.R., Mir S.A., Gangoo A.A., Shah S., and Banday K. Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder. Scand J Urol Nephrol 31 3 (1997) 295-296
199. Usalan C., and Emri S. Membranoproliferative glomerulonephritis associated with small cell lung carcinoma. Int Urol Nephrol 30 2 (1998) 209-213
200. Enriquez R., Sirvent A.E., Cabezuelo J.B., Perez-Ramos M., Amoros F., and Reyes A. Membranoproliferative glomerulonephritis and gastric adenocarcinoma. Nephrol Dial Transplant 14 1 (1999) 242-243
201. Han B.G., Kim M.H., Karl E.H., Hong S.W., and Choi S.O. A case of membranoproliferative glomerulonephritis associated with a hydatidiform mole. Yonsei Med J 41 3 (2000) 407-410
202. Salazar-Exaire D., Rodriguez A., Galindo-Rujana M.E., et al. Membranoproliferative glomerulonephritis associated with a mixed-cell germinal ovary tumor. Am J Nephrol 21 1 (2001) 51-54
203. Paydas S., Soydas B., Paydas S., Balal M., Erdogan S., and Tuncer I. Different glomerulopathies accompanying non-small-cell lung cancer. Mt Sinai J Med 72 4 (2005) 279-281
204. Idrees M.T., Hessler R., Terris D., Mixson C., and Wang B.Y. Unusual polypoid laryngeal myxoma. Mt Sinai J Med 72 4 (2005) 282-284
205. Rahman R.C., Pollono D., Drut R., and Spizzirri F.D. Malignancy-associated membranoproliferative glomerulonephritis. Pediatr Nephrol 11 2 (1997) 208-209
206. Tydings A., Weiss R.R., Lin J.H., Bennett J., and Tejani N. Renal-cell carcinoma and mesangiocapillary glomerulonephritis presenting as severe pre-eclampsia. N Y State J Med 78 12 (1978) 1950-1954
207. Esnault V.L., Moreau A., Testa A., and Besnier D. Crescentic glomerulonephritis. Nephrol Ther 2 7 (2006) 446-460
208. Whitworth J.A., Morel-Maroger L., Mignon F., and Richet G. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron 16 1 (1976) 1-19
209. Biava C.G., Gonwa T.A., Naughton J.L., and Hopper Jr. J. Crescentic glomerulonephritis associated with nonrenal malignancies. Am J Nephrol 4 4 (1984) 208-214
210. Skaarup P., Jorgensen T., and Larsen S. Asynchronous metastasizing renal cell carcinoma associated with progressive immune complex glomerulonephritis and proteinuria. Scand J Urol Nephrol 18 4 (1984) 351-356
211. Perl S.I., Yong J.C., and Higgins S.G. Tumor crescents from intraglomerular metastases. Clin Nephrol 27 5 (1987) 260-262
212. Hatakeyama S., Kawano M., Konosita T., et al. A case of renal cell carcinoma associated with rapidly progressive glomerulonephritis. Nippon Jinzo Gakkai Shi 32 10 (1990) 1125-1132
213. Dussol B., Berland Y., and Casanova P. Crescentic Glomerulonephritis associated with gastric adenocarcinoma. Nephrologie 13 4 (1992) 163-165
214. Irish A.B., Savdie E., and Delprado W. Simultaneous presentation of gastric carcinoma and crescentic glomerulonephritis. Nephron 60 2 (1992) 254
215. Edgar J.D., Rooney D.P., McNamee P., and McNeill T.A. An association between ANCA positive renal disease and malignancy. Clin Nephrol 40 1 (1993) 22-25
216. Kagan A., Sinay-Trieman L., Czernobilsky B., Barzilai N., and Bar-Khayim Y. Is the association between crescentic glomerulonephritis and renal cell carcinoma coincidental?. Nephron 65 4 (1993) 642-643
217. Hruby Z., Bronowicz A., Rabczynski J., Kopec W., and Szewczyk Z. A case of severe anti-neutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis and asymptomatic gastric cancer. Int Urol Nephrol 26 5 (1994) 579-586
218. Comolli R.R., Zabala J.R., Suarez A.A., and Bravo A.I. Small cell pulmonary carcinoma, nephrotic syndrome and kidney failure of rapid evolution. Medicina (B Aires) 54 2 (1994) 153-158
219. Parker M.G., Atkins M.B., Ucci A.A., and Levey A.S. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol 5 10 (1995) 1740-1744
220. Suwa A., Inada S., Tanabe M., et al. An autopsy case of anti-neutrophil cytoplasmic antibodies associated vasculitis accompanied by autoimmune hepatitis and hepatocellular carcinoma. Nihon Rinsho Meneki Gakkai Kaishi 20 2 (1997) 117-125
221. Yedidag A., Zikos D., Spargo B., MacEntee P., and Berkelhammer C. Esophageal carcinoma presenting with nephrotic syndrome: association with anti-neutrophil cytoplasmic antibody. Am J Gastroenterol 92 2 (1997) 326-328
222. Sommer M., Schmidt R., Lambrecht E., Fink H., Geiger H., and Lenz T. Rapidly progressive glomerulonephritis in a patient with advanced renal cell carcinoma. Nephrol Dial Transplant 13 8 (1998) 2107-2109
223. Maes B., Vanwalleghem J., Kuypers D., Van Damme B., Waer M., and Vanrenterghem Y. IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy. Am J Kidney Dis 33 2 (1999) E3
224. Karim M.Y., Frankel A., Paradinas F.J., and Moss J. Anti-neutrophil cytoplasmic antibody-positive crescentic nephritis occurring together with renal cell carcinoma. Nephron 85 4 (2000) 368-370
225. Baschinsky D.Y., Baker P.B., Niemann T.H., and Wilmer W.A. Pauci-immune ANCA-positive crescentic glomerulonephritis associated with metastatic adenocarcinoma of the lung. Am J Kidney Dis 36 4 (2000) E24
226. Jain S., Kakkar N., Joshi K., and Varma S. Crescentic glomerulonephritis associated with renal cell carcinoma. Ren Fail 23 2 (2001) 287-290
227. Lorenz M., Regele H., Kovarik J., Horl W.H., and Klauser R. Rapidly progressive glomerulonephritis and carcinoma of the hypopharynx. Am J Kidney Dis 37 1 (2001) E3
228. Norris J.H., Leeds J., and Jeffrey R.F. P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy. Ren Fail 25 2 (2003) 311-314
229. Yavuzsen T., Oztop I., Yilmaz U., et al. Gastric cancer diagnosed in a patient with crescentic glomerulonephritis. Gastric Cancer 6 4 (2003) 267-269
230. Nakaya I., Iwata Y., Abe T., Yokoyama H., Oda Y., and Nomura G. Malignant gastrointestinal stromal tumor originating in the lesser omentum, complicated by rapidly progressive glomerulonephritis and gastric carcinoma. Intern Med 43 2 (2004) 102-105
231. Kai H., Yamagata K., Usui J., et al. Crescentic glomerulonephritis associated with renal cell carcinoma after cancer immunotherapy. J Nephrol 18 4 (2005) 436-441
232. Parambil J.G., Keogh K.A., Fervenza F.C., and Ryu J.H. Microscopic polyangiitis associated with thymoma, exacerbating after thymectomy. Am J Kidney Dis 48 5 (2006) 827-831
233. Diez-Porres L., Rios-Blanco J.J., Robles-Marhuenda A., Gutierrez-Molina M., Gil-Aguado A., and Vazquez-Rodriguez J.J. ANCA-associated vasculitis as paraneoplastic syndrome with colon cancer: a case report. Lupus 14 8 (2005) 632-634
234. Navarro J.F., Quereda C., Rivera M., Navarro F.J., and Ortuno J. Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis. Postgrad Med J 70 823 (1994) 373-375
235. Tatsis E., Reinhold-Keller E., Steindorf K., Feller A.C., and Gross W.L. Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum 42 4 (1999) 751-756
236. Vanatta P.R., Silva F.G., Taylor W.E., and Costa J.C. Renal cell carcinoma and systemic amyloidosis: demonstration of AA protein and review of the literature. Hum Pathol 14 3 (1983) 195-201
237. Glenner G.G. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med 302 23 (1980) 1283-1292
238. Tsai H.M. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 14 4 (2003) 1072-1081
239. Humphreys B.D., Soiffer R.J., and Magee C.C. Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol 16 1 (2005) 151-161
240. Werner T.L., Agarwal N., Carney H.M., and Rodgers G.M. Management of cancer-associated thrombotic microangiopathy: what is the right approach?. Am J Hematol (2006)
241. Kressel B.R., Ryan K.P., Duong A.T., Berenberg J., and Schein P.S. Microangiopathic hemolytic anemia, thrombocytopenia, and renal failure in patients treated for adenocarcinoma. Cancer 48 8 (1981) 1738-1745
242. Lohrmann H.P., Adam W., Heymer B., and Kubanek B. Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases. Ann Intern Med 79 3 (1973) 368-375
243. Zheng H.L., Maruyama T., Matsuda S., and Satomura K. Neuroblastoma presenting with the nephrotic syndrome. J Pediatr Surg 14 4 (1979) 414-419
244. Papper S. Nephrotic syndrome and neoplasm. The findings to date, with practical implications. Postgrad Med 76 6 (1984) 147-148 153-158
245. Drash A., Sherman F., Hartmann W.H., and Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76 4 (1970) 585-593
246. Frasier S.D., Bashore R.A., and Mosier H.D. Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins. J Pediatr 64 (1964) 740-745
247. Donckerwolcke R., and Cameron J. The nephrotic syndrome. In: Davison A., Cameron J., Grünfeld J., Ponticelli C., Ritz E., Winearls C., et al. (Eds). Oxford textbook of clinical nephrology (2005), Oxford University Press, Oxford 415-438
248. Jefferson J.A., and Couser W.G. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol 23 4 (2003) 400-405
249. Gulati S., Kher V., Gulati K., Arora P., and Gujral R. Tuberculosis in childhood nephrotic syndrome in India. Pediatr Nephrol 11 6 (1997) 695-698
250. Singhal R., and Brimble K.S. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 118 3 (2006) 397-407
251. Di Micco P., Amitrano M., Niglio A., and Fontanella A. Molecular and clinical conditions associated with venous thromboembolism in oncological patients. Exp Oncol 28 3 (2006) 194-197
252. Combe C., and Aparicio M. Protein metabolism during nephrotic syndrome. Experimental and clinical influence of dietary protein intake. Nephrologie 14 4 (1993) 171-175